Oliver Findl
Prof. Dr. Oliver Findl, President of the ESCRS, will introduce an modern know-how poised to revolutionize the lives of cataract sufferers.
— Andreas C. Kühnel, Managing Director at VSY Biotechnology GmbH
LEINFELDEN-ECHTERDINGEN, GERMANY, August 23, 2023/EINPresswire.com/ — Prof. Dr. Oliver Findl, President of the European Society of Cataract and Refractive Surgeons (ESCRS), will introduce an modern know-how poised to revolutionize the lives of cataract sufferers. Prof. Dr. Findl will showcase VSY Biotechnology’s groundbreaking Enova Advancedtm Non-Diffractive Hydrophobic EDoF IOL, the most recent addition to its IOL portfolio.
This transformative know-how can be unveiled at VSY Biotechnology’s Satellite tv for pc Symposium in the course of the ESCRS Congress in Vienna on September 9, 2023 from 16:00 to 17:00 in Room Strauss 2.
The satellite tv for pc symposium will supply ophthalmic professionals a novel probability to discover the Enova Advancedtm Edof IOL’s attributes, composition, and affect on sufferers’ visible experiences. Prof. Dr. Oliver Findl will share his experience and first-hand experiences with the Enova AdvancedTM EDoF IOL. Dr. Detlef Holland, Prof. Dr. Achim Langenbucher, and Dr. Florian Kretz may also contribute considerably to the symposium by delving into the subject of presbyopia correction and presenting the medical outcomes of the Enova AdvancedTM EDoF IOL.
Commenting on the brand new innovation, Andreas C. Kühnel, Managing Director at VSY Biotechnology GmbH, acknowledged: “The Enova AdvancedTM EDoF IOL redefines ophthalmic care with unparalleled visible acuity, adaptability, and affected person satisfaction. Its Mild Tailoring Technology ensures distinctive far and intermediate imaginative and prescient, extending to close to imaginative and prescient, with minimal halo and glare. Built-in with the hydrophobic Enova® IOL materials platform, it presents 100% glistening-free efficiency, handy dry-packing, and dependable unfolding in various temperatures for constant outcomes.”
Andreas Kühnel
VSY Biotechnology
+49 711 997606333
electronic mail us right here
ESCRS President Oliver Findl to Introduce New IOL Technology for Cataract Patients
This post first appeared on Enablement Is The Key For Organisational Growth, please read the originial post: here
